Gossamer Bio Inc
(NAS:GOSS)
$
0.6981
-0.0036 (-0.51%)
Market Cap: 158.19 Mil
Enterprise Value: 34.78 Mil
PE Ratio: 0
PB Ratio: 2.92
GF Score: 36/100 Gossamer Bio Inc at Bank of America Global Research Healthcare Conference (Virtual) Transcript
May 11, 2021 / 08:15PM GMT
Release Date Price:
$8.31
(+3.88%)
Geoffrey Christopher Meacham
BofA Securities, Research Division - Research Analyst
Okay. Welcome to the afternoon sessions for the Virtual Vegas BofA Healthcare Conference. My name is Geoff Meacham. I'm the senior biopharma analyst here at BofA. I have Olivia Brayer with me from my team as well. And we're thrilled this afternoon to have Gossamer Biotech. And speaking on behalf of Gossamer, we have Faheem Hasnain, CEO. We have Bryan Giraudo.
(technical difficulty)
(inaudible) Hey, guys. How's it going?
Faheem Hasnain
Gossamer Bio, Inc. - Co-Founder, CEO, President & Chairman
Great, Geoff. Good to see you again.
Bryan Giraudo
Gossamer Bio, Inc. - CFO
Thanks, Geoff.
Geoffrey Christopher Meacham;Faheem Hasnain
BofA Securities, Research Division - Research Analyst;Gossamer Bio, Inc. - Co
Good to see your face. Yes. Faheem, I thought you're the Ronaldo of biotech. I should just call you Faheem with no last name.
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot